JCB logo
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1083/jcb.200811105
The Journal of Cell Biology, Vol. 185, No. 2, 291-303
The Rockefeller University Press, 0021-9525 $30.00
© Manzl et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 3614K)
Right arrow PDF+supp data (4820K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manzl, C.
Right arrow Articles by Villunger, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manzl, C.
Right arrow Articles by Villunger, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Caspase-2 activation in the absence of PIDDosome formation



Claudia Manzl1, Gerhard Krumschnabel1, Florian Bock1, Benedicte Sohm1, Verena Labi1, Florian Baumgartner1, Emmanuelle Logette2, Jürg Tschopp2, and Andreas Villunger1

1 Division of Developmental Immunology, Biocenter, Innsbruck Medical University, A-6020 Innsbruck, Austria
2 Department of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland

Correspondence to Andreas Villunger: Andreas.Villunger{at}i-med.ac.at

PIDD (p53-induced protein with a death domain [DD]), together with the bipartite adapter protein RAIDD (receptor-interacting protein-associated ICH-1/CED-3 homologous protein with a DD), is implicated in the activation of pro–caspase-2 in a high molecular weight complex called the PIDDosome during apoptosis induction after DNA damage. To investigate the role of PIDD in cell death initiation, we generated PIDD-deficient mice. Processing of caspase-2 is readily detected in the absence of PIDDosome formation in primary lymphocytes. Although caspase-2 processing is delayed in simian virus 40–immortalized pidd–/– mouse embryonic fibroblasts, it still depends on loss of mitochondrial integrity and effector caspase activation. Consistently, apoptosis occurs normally in all cell types analyzed, suggesting alternative biological roles for caspase-2 after DNA damage. Because loss of either PIDD or its adapter molecule RAIDD did not affect subcellular localization, nuclear translocation, or caspase-2 activation in high molecular weight complexes, we suggest that at least one alternative PIDDosome-independent mechanism of caspase-2 activation exists in mammals in response to DNA damage.


Abbreviations used in this paper: DD, death domain; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; MEF, mouse embryonic fibroblast; MOMP, mitochondrial outer membrane permeabilization; mPIDD, mouse PIDD; NF-{kappa}B, nuclear factor {kappa}B; PE, phycoerythrin; PI, propidium iodide; Puma, p53 up-regulated modulator of apoptosis; UVR, UV radiation.

© 2009 Manzl et al.
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jcb.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents